Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

EU Medtech Reform Proposals May Jeopardize Authorized Reps And Exacerbate 'Ghost' Problem

This article was originally published in Clinica

Executive Summary

A new clause in the draft EU regulations for medical devices and IVDs - to make authorized representatives fully liable for defective devices in cases where the product manufacturer is not established in any EU member state - could have a devastating effect on how independent authorized representatives operate and force many of them to shut shop, warns the European Association of Authorised Representatives.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst